Today: 27 June 2026
MercadoLibre stock pops back over $2,000 as MELI eyes Feb. 24 results
9 February 2026
1 min read

MercadoLibre stock pops back over $2,000 as MELI eyes Feb. 24 results

New York, February 9, 2026, 13:18 ET — Regular session

  • MercadoLibre climbed roughly 1.8% in the afternoon, reclaiming the $2,000 mark on its shares.
  • U.S. growth stocks pushed higher, with Latin American equities also showing more strength, and the move followed suit.
  • Investors are making moves ahead of MercadoLibre’s provisional quarterly results date on Feb. 24.

MercadoLibre Inc shares bounced 1.8% higher to close at $2,004.94 on Monday, regaining ground above the $2,000 line after slipping as low as $1,962.64 earlier in the session.

The move is drawing attention as the clock ticks down for both MercadoLibre bulls and skeptics. No new company news has hit the wires, so focus is shifting to the earnings report coming up later this month—a key event on traders’ radar.

This leaves sentiment driving the action day to day. MercadoLibre—a pricey Latin America e-commerce and payments play—often swings harder than the overall market during shifts in risk preference.

Stocks in the U.S. moved higher this day. The S&P 500 tracker added roughly 0.6%, and the Nasdaq 100 tracker advanced about 0.9%. A Latin America equity ETF outperformed, up close to 1.8%. Amazon barely budged; Sea slipped slightly.

MercadoLibre runs an e-commerce platform and its fintech arm, Mercado Pago, throughout Latin America. For investors, the stock tends to signal shifts in consumer appetite, payment volumes, and how well logistics are handled in the region.

According to the company’s investor relations calendar, fourth-quarter results are tentatively set for February 24. A Morgan Stanley conference in New York lands a month later, on March 24.

As results hit, investors zero in on any new details about commerce volumes, payment trends, and margins. Gross merchandise volume, or GMV, usually gets extra attention — traders like it for its clearer snapshot of demand compared to just looking at revenue.

Still, heading into an earnings release, things can swing either direction. If the U.S. dollar strengthens or local currencies slide, that dents reported numbers. Investors are also likely to punish any uptick in credit losses across payments and lending harder than normal.

Next up: MercadoLibre faces a key moment on Feb. 24, set to brief investors about holiday-quarter trends and lay out its spending priorities — as well as areas slated for cuts — in 2026.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Strategy Stock Drops Nearly 25% Amid Crypto Market Turmoil
    June 27, 2026, 10:34 AM EDT. Strategy (MSTR) shares plunged 24.80% last week, triggering fresh concern across cryptocurrency investors. The fall added pressure on the market amid broader crypto volatility. Experts attribute the slide to amplified fears regarding bitcoin and other digital assets, with investors pulling back. Strategy, heavily linked to crypto through its bitcoin holdings, remains a bellwether for the sector. The drop underscores ongoing instability in digital asset markets and heightened sensitivity to regulatory and market shifts.

Latest articles

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

27 June 2026
ImmunityBio surged 11.8% to $8.71 on Friday with volume tripling its average, as Russell index reconstitution took effect; Monday’s trading will reveal if demand persists or if the spike was driven by index flows, with no imminent company events and recent insider selling accounting for just 0.06% of Friday’s volume.
Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

27 June 2026
Lucid surged 15.6% Friday, adding $312 million in equity value—almost double the $158 million in annualized savings from this week’s restructuring plan that cut 18% of its U.S. workforce. Friday’s volume equaled 54% of reported short interest, but the rally outpaced cost-cutting fundamentals, leaving less room for further gains based solely on headcount cuts.
Court ruling on student loans hits private lenders’ health grad loan push

Court ruling on student loans hits private lenders’ health grad loan push

27 June 2026
Judge blocks narrow “professional degree” rule, letting more health-care grad students keep higher federal loan caps; $7.87B in 2023-24 borrowing above new limits remains in federal market, trimming but not eliminating the $4.5B-$5B annual private loan growth Sallie Mae projected from Grad PLUS loan cuts.
Moderna (NASDAQ:MRNA) price targets draw attention as shares rally into short holiday week

Moderna (NASDAQ:MRNA) price targets draw attention as shares rally into short holiday week

27 June 2026
Moderna soared 12.6% Friday on heavy volume after unveiling new in vivo CAR-T pipeline plans, closing at $67.27—52% above the mean analyst target but still 14.5% below Piper Sandler’s new $77 target. The rally followed Science Day updates, even as analysts note the main new asset is preclinical and cash burn continues, with $7.5B cash at March-end and a projected $3B R&D spend for 2026.
US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data
Previous Story

US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Next Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Go toTop